Abstract
Background Malaria constitutes a major public health burden in sub-Saharan Africa. It remains a key health concern and the leading cause of death in children under five years of age in Benin. Since October 2021, the World Health Organization has recommended the use of malaria vaccines for the prevention of Plasmodium falciparum malaria in children living in malaria endemic areas, prioritizing areas of moderate and high transmission in sub-Saharan Africa. However, with the exception of Ghana, there is a scarcity of studies modelling the potential impact of the RTS,S/AS01 vaccine in the context of West Africa. This study addresses a gap in research by modelling the impact of malaria childhood vaccination on Plasmodium falciparum malaria transmission in Benin.
Methods A compartmental mathematical model has been developed to estimate clinical and severe malaria cases averted in children under the age of five with the primary series (3 doses) of the RTS,S/AS01 malaria vaccine in Benin. Over a period of 10 years, scenarios including vaccine introduction at different coverage levels to supplement the use of long-lasting insecticidal nets to assess the impact of the RTS,S/AS01 vaccine on malaria transmission in Benin are modelled.
Results The model projected malaria burden alleviation by malaria vaccination in Benin. The combination of childhood malaria vaccination at a coverage equivalent to the national DTP3 coverage and the current use of long-lasting insecticidal nets is projected to result in 40% reduction in malaria clinical cases and deaths among children under five years old compared to using nets alone, from 2025 to 2034. However, if the introduction of a malaria vaccine has the unintended consequence of decreased net use, cumulative benefits may be offset. A 1.5-fold decrease in the use of long-lasting insecticidal nets is projected to result in an increase in malaria burden, surpassing baseline levels despite the introduction of the vaccine.
Conclusion This modelling exercise concludes that childhood vaccination is expected to avert clinical and severe cases of malaria and is an additional tool to advance malaria control efforts in Benin but potential unintended consequences of a reduction in net usage may reduce these gains.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [Grant number INV047-048]. Under the grant conditions of the Foundation, a Creative Commons Attribution Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The analysis has been updated with new scenarios. Previously, four scenarios were considered; in the current version, all four have been revised and two new scenarios have been added, resulting in a total of six scenarios. Three new authors have contributed to the manuscript.
Data Availability
The data used in this study are open access and freely available from the respective sources.
